VA Puget Sound Healthcare System, University of Washington, Seattle, WA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washingon, Seattle, WA.
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washingon, Seattle, WA; Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA.
Chest. 2023 Mar;163(3):707-718. doi: 10.1016/j.chest.2022.09.038. Epub 2022 Oct 6.
Patient understanding of chest low-dose CT (LDCT) scan results for lung cancer screening (LCS) may impact outcomes.
What are patient- and clinician-identified gaps in understanding and communication of LCS results and how might communication be improved through a patient-oriented tool?
We performed a mixed-methods study of participants recruited from a multisite LCS program to understand knowledge gaps after receiving LCS results and to guide development of a commonly asked questions (CAQ) after LCS information sheet. Initial patient surveys assessed understanding and reactions to LCS results (n = 190). We then conducted patient interviews and focus group discussions (n = 31) to understand experiences receiving LDCT scan results and reactions to results letters and the proposed CAQ; we also interviewed clinicians (n = 6) for feedback on these resources. We summarized survey responses and used thematic analysis to identify major themes in focus groups and interviews.
Of 190 survey respondents (43% response rate), although 88% agreed that they "understood" their LCS results, only 55% reported understanding what a lung nodule is. Approximately two-thirds thought it was "very important" to receive more information regarding lung nodules and incidental lung and heart disease. In interviews and focus groups, although patients believed that brief results letters for normal LDCT scan results generally were acceptable, most found letters explaining abnormal LDCT scan and incidental findings to be concerning and not a substitute for discussion with their clinician. Nearly all patients expressed that the CAQ sheet provided helpful information on nodules, results reporting and incidental findings, and helped them form questions to ask their clinicians.
We identified patient-reported information needs regarding LCS results and developed a CAQ information sheet that was refined with patient and clinician input. The CAQ may represent a simple and feasible way to improve LCS results reporting and to augment clinician-patient discussions.
患者对肺癌筛查(LCS)用胸部低剂量 CT(LDCT)扫描结果的理解可能会影响结果。
患者和临床医生在理解和沟通 LCS 结果方面存在哪些差距,以及通过以患者为导向的工具如何改善沟通?
我们对来自多地点 LCS 计划的参与者进行了一项混合方法研究,以了解接受 LCS 结果后的知识差距,并为 LCS 信息表后的常见问题(FAQ)提供指导。最初的患者调查评估了对 LCS 结果的理解和反应(n=190)。然后,我们进行了患者访谈和焦点小组讨论(n=31),以了解接受 LDCT 扫描结果的经验以及对结果信件和拟议的 FAQ 的反应;我们还采访了临床医生(n=6),以获取对这些资源的反馈。我们总结了调查结果,并使用主题分析在焦点小组和访谈中确定主要主题。
在 190 名调查受访者中(43%的回应率),尽管 88%的人表示他们“理解”他们的 LCS 结果,但只有 55%的人报告说理解肺结节是什么。大约三分之二的人认为收到更多关于肺结节以及偶然的肺部和心脏疾病的信息是“非常重要的”。在访谈和焦点小组中,尽管患者认为正常 LDCT 扫描结果的简短结果信件通常是可以接受的,但大多数人认为解释异常 LDCT 扫描和偶然发现的信件令人担忧,不能替代与他们的临床医生讨论。几乎所有的患者都表示,FAQ 表提供了有关结节、结果报告和偶然发现的有用信息,并帮助他们形成向临床医生提问的问题。
我们确定了患者对 LCS 结果的报告信息需求,并开发了一个 FAQ 信息表,该表在患者和临床医生的投入下进行了改进。FAQ 可能代表了一种简单而可行的方法,可以改善 LCS 结果报告,并增强临床医生与患者的讨论。